文献速递慢性静脉疾病

静脉临床严重程度评分在髂静脉支架置入术后三年随访中检测改善的能力欠佳

Venous Clinical Severity Score has a suboptimal ability to detect improvement after iliac vein stenting across three years of follow-up.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2023-03-09

该研究回顾性分析了2011年8月至2021年6月期间因慢性近端静脉流出道梗阻接受髂股静脉支架置入的433例患者,随访超过1年。以临床评估评分(CAS)>0为改善标准,静脉临床严重程度评分(VCSS)变化值在1年、2年和3年的曲线下面积分别为0.764、0.753和0.715,阈值为+2.5时敏感性分别为74.9%、70.7%和76.2%,特异性分别为70.0%、66.7%和58.1%。结论认为VCSS变化值检测临床改善的能力欠佳。

要点

  • VCSS变化值在髂静脉支架术后1年、2年、3年的AUC分别为0.764、0.753、0.715,判别能力欠佳。
  • VCSS变化阈值+2.5在三个时间点均最大化敏感性和特异性。
  • 阈值+2.5时敏感性为74.9%、70.7%、76.2%,特异性为70.0%、66.7%、58.1%。

核心结论

  • 在3年随访中,VCSS变化值检测慢性近端静脉流出道梗阻患者髂静脉支架置入术后临床改善的能力欠佳,阈值为2.5时敏感性尚可但特异性可变。

研究设计与样本

  • 回顾性分析2011年8月至2021年6月期间因慢性近端静脉流出道梗阻接受髂股静脉支架置入的433例患者注册数据,这些患者随访超过1年。
  • 以临床评估评分(CAS)>0定义为改善,CAS≤0定义为无改善,比较VCSS变化值与CAS。
  • 使用受试者工作特征曲线和曲线下面积(AUC)评估VCSS变化值在每年随访时区分改善与无改善的能力。

主要发现

  • VCSS变化值判别临床改善的AUC在1年为0.764,2年为0.753,3年为0.715。
  • 在三个时间点,VCSS变化阈值+2.5均最大化检测临床改善的敏感性和特异性。
  • 1年时,阈值+2.5的敏感性为74.9%,特异性为70.0%。
  • 2年时,VCSS变化的敏感性为70.7%,特异性为66.7%。
  • 3年随访时,VCSS变化的敏感性为76.2%,特异性为58.1%。

关键数值与推荐

  • 改善定义为CAS>0,无改善定义为CAS≤0。
  • CAS评分:恶化(-1)、无变化(0)、轻度改善(+1)、显著改善(+2)、无症状/完全缓解(+3)。
  • VCSS变化阈值+2.5在1年、2年、3年随访中均最大化敏感性和特异性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Venous Clinical Severity Score (VCSS) is currently the gold standard for measuring the severity of chronic venous disease, especially in patients with chronic proximal venous outflow obstruction (PVOO) secondary to non-thrombotic iliac vein lesions. Change in VCSS composite scores is often used to quantitatively measure the degree of clinical improvement after venous interventions. This study sought to assess the discriminative ability, sensitivity, and specificity of change in VCSS composites for detecting clinical improvement after iliac venous stenting. METHODS: A registry of 433 patients who underwent iliofemoral vein stenting for chronic PVOO from August 2011 to June 2021 was retrospectively analyzed. These 433 patients had follow-up exceeding 1 year after the index procedure. Change in VCSS composite and clinical assessment scores (CAS) were used to quantify improvement after venous interventions. CAS is an assessment by the operating surgeon based on patient self-reporting to assess the degree of improvement at each clinic visit compared with before the index procedure longitudinally across the treatment course of a patient. Patients are rated as worse (-1), no change (0), mildly improved (+1), significantly improved (+2), and asymptomatic/complete resolution (+3) at every follow-up visit as compared with their disease severity prior to the procedure based on patient self-report. This study defined improvement as CAS >0 and no improvement as CAS ≤0. VCSS was then compared with CAS. Receiver operative characteristic curve and area under the curve (AUC) were used to evaluate change in VCSS composite for its ability to discriminate between improvement and no improvement after intervention at each year of follow-up. RESULTS: Change in VCSS was a suboptimal measure for discriminating clinical improvement (1-year AUC, 0.764; 2-year AUC, 0.753; 3-year AUC, 0.715). Across all three time points, a change in VCSS threshold of +2.5 maximized the sensitivity and specificity of the instrument to detect clinical improvement. At 1 year, change in VCSS at this threshold was able to detect clinical improvement at a sensitivity of 74.9% and specificity of 70.0%. At 2 years, VCSS change had a sensitivity of 70.7% and specificity of 66.7%. At 3 years of follow-up, VCSS change had a sensitivity of 76.2% and specificity of 58.1%. CONCLUSIONS: Across 3 years, change in VCSS exhibited a suboptimal ability to detect clinical improvement in patients undergoing iliac vein stenting for chronic PVOO with considerable sensitivity but variable specificity at a threshold of 2.5.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Bai H, Storch JB, Chen J, et al. Venous Clinical Severity Score has a suboptimal ability to detect improvement after iliac vein stenting across three years of follow-up. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36906105. doi:10.1016/j.jvsv.2023.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。